New hope for lymphoma patients: mosunetuzumab under review
Disease control
Recruiting now
This study looks back at medical records of 25 adults with follicular lymphoma that returned or didn't respond to at least two prior treatments. All patients received mosunetuzumab through a compassionate use program. Researchers want to see how well the drug works and what side …
Sponsor: Andrés José Maria Ferreri • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC